HAS GENE THERAPY STALLED?

SCIENTISTS MAY HAVE PUSHED TOO FAR TOO FAST IN A RACE FOR BREAKTHROUGHS

Like every medical revolution before it, the field of gene therapy began with the vision of a brighter future. Researchers promised to cure such hereditary disorders as cystic fibrosis, muscular dystrophy and sickle-cell anemia, not with conventional medicine but with the magic of genetic engineering, supplanting defective genes with their normal counterparts. Patients dreamed of a life free of the diseases they had inherited. Venture capitalists dreamed of untold riches and backed the leading researchers in the field with millions of dollars of seed money.

But turning visions into reality has always been the trickiest step in conducting a successful revolution....

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!